210 related articles for article (PubMed ID: 24405692)
1. Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
Blonder JP; Mutka SC; Sun X; Qiu J; Green LH; Mehra NK; Boyanapalli R; Suniga M; Look K; Delany C; Richards JP; Looker D; Scoggin C; Rosenthal GJ
BMC Pulm Med; 2014 Jan; 14():3. PubMed ID: 24405692
[TBL] [Abstract][Full Text] [Related]
2. Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma.
Que LG; Yang Z; Lugogo NL; Katial RK; Shoemaker SA; Troha JM; Rodman DM; Tighe RM; Kraft M
Immun Inflamm Dis; 2018 Jun; 6(2):322-331. PubMed ID: 29642282
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
Saxena N; Won J; Choi S; Singh AK; Singh I
Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosoglutathione supplementation to ovalbumin-sensitized and -challenged mice ameliorates methacholine-induced bronchoconstriction.
Foster MW; Yang Z; Potts EN; Michael Foster W; Que LG
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L739-44. PubMed ID: 21784966
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase.
Green LS; Chun LE; Patton AK; Sun X; Rosenthal GJ; Richards JP
Biochemistry; 2012 Mar; 51(10):2157-68. PubMed ID: 22335564
[TBL] [Abstract][Full Text] [Related]
6. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
Sun X; Wasley JW; Qiu J; Blonder JP; Stout AM; Green LS; Strong SA; Colagiovanni DB; Richards JP; Mutka SC; Chun L; Rosenthal GJ
ACS Med Chem Lett; 2011 May; 2(5):402-6. PubMed ID: 24900320
[TBL] [Abstract][Full Text] [Related]
7. A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
Colagiovanni DB; Drolet DW; Langlois-Forget E; Piché MP; Looker D; Rosenthal GJ
Regul Toxicol Pharmacol; 2012 Feb; 62(1):115-24. PubMed ID: 22210450
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Stout AM; Mutka SC; Richards JP; Rosenthal GJ
Bioorg Med Chem Lett; 2012 Mar; 22(6):2338-42. PubMed ID: 22342142
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Mutka SC; Stout AM; Richards JP; Rosenthal GJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5849-53. PubMed ID: 21855338
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
[TBL] [Abstract][Full Text] [Related]
11. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke.
Khan M; Kumar P; Qiao F; Islam SMT; Singh AK; Won JS; Feng W; Singh I
Brain Res; 2020 Aug; 1741():146879. PubMed ID: 32418890
[TBL] [Abstract][Full Text] [Related]
12. Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-κB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin-induced murine asthma model.
Huang M; Wei Y; Dong J
Pulm Pharmacol Ther; 2020 Dec; 65():102005. PubMed ID: 33636365
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Colagiovanni DB; Mutka SC; Blonder JP; Stout AM; Richards JP; Chun L; Rosenthal GJ
Bioorg Med Chem Lett; 2011 Jun; 21(12):3671-5. PubMed ID: 21570838
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of inhaled R- and S-terbutaline in ovalbumin-induced asthmatic mice.
Beng H; Su H; Wang S; Kuai Y; Hu J; Zhang R; Liu F; Tan W
Int Immunopharmacol; 2019 Aug; 73():581-589. PubMed ID: 31234092
[TBL] [Abstract][Full Text] [Related]
15. Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper-relaxant responses to S-nitrosoglutathione in a hyperoxic murine model.
Einisman HJ; Gaston B; Wijers C; Smith LA; Lewis TH; Lewis SJ; Raffay TM
Pediatr Pulmonol; 2019 Dec; 54(12):1989-1996. PubMed ID: 31486289
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells.
Yang Z; Bochkov YA; Voelker DR; Foster MW; Que LG
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):58-67. PubMed ID: 30156431
[TBL] [Abstract][Full Text] [Related]
17. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase.
Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B
Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866
[TBL] [Abstract][Full Text] [Related]
18. S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke.
Khan M; Dhammu TS; Qiao F; Kumar P; Singh AK; Singh I
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104470. PubMed ID: 31680031
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice.
Kim J; Qiao F; Singh AK; Won J; Singh I
Front Pharmacol; 2023; 14():1304697. PubMed ID: 38143504
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosoglutathione Reductase Is Essential for Protecting the Female Heart From Ischemia-Reperfusion Injury.
Casin KM; Fallica J; Mackowski N; Veenema RJ; Chan A; St Paul A; Zhu G; Bedja D; Biswal S; Kohr MJ
Circ Res; 2018 Nov; 123(11):1232-1243. PubMed ID: 30571462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
